Shelter dogs do better with a buddy, a new study finds. Dogs show fewer signs of stress and are adopted more quickly if paired up with another canine rather than housed by themselves, researchers found. “Despite being a social species, dogs are often housed alone in shelters to reduce disease transmission and possible injury from… read on > read on >
After helping America through one of its worst tragedies, some responders to the events of 9/11 may now face another foe: Heightened risks for dementia. A new study looks at the health of thousands of firemen, construction workers and others who worked at the World Trade Center (WTC) site for almost a year after the… read on > read on >
Many Louisiana residents are being exposed to a cancer-causing toxic gas that’s used in industrial settings, researchers report. A cutting-edge mobile air-testing lab found dangerous levels of ethylene oxide along large stretches of Louisiana, sometimes at levels a thousand times higher than what is considered safe, according to findings published June 11 in the journal… read on > read on >
The U.S. Food and Drug Administration announced Monday that it has joined up with the Department of Justice and several other federal agencies to do more to stop the sale of illegal e-cigarettes in this country. In launching the newly created task force, the FDA aims “to coordinate and streamline efforts to bring all available… read on > read on >
Winston Churchill once said, “Success consists of going from failure to failure without loss of enthusiasm.” It’s one of countless platitudes claiming that failure leads to success. But there’s strong evidence that such a notion is wrongheaded and can lead to terrible real-world consequences, researchers said in a new report. In fact, many people do… read on > read on >
The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. Drugmaker GSK’s Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults… read on > read on >
An experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday. The shot — for now called mRNA-1083 — “has met its primary endpoints, eliciting a higher immune response than the licensed comparator vaccines used in the trial,” Moderna said… read on > read on >
A plant-based eating regimen designed to save the Earth also saves people’s lives, a large study confirms. “Shifting how we eat can help slow the process of climate change,” said corresponding author Dr. Walter Willett, a professor of epidemiology and nutrition at Harvard T.H. Chan School of Public Health. “And what’s healthiest for the planet… read on > read on >
Researchers have developed a novel way to promote hair growth in people who have the autoimmune disease alopecia areata. It’s a skin patch that delivers immune-system controllers through an array of tiny needles. In alopecia, the body’s own T-cells mistakenly attack hair follicles. The experimental treatment strategy uses a patch to deliver specialized cells called… read on > read on >
If tropical lands like South America or Africa are your travel destinations, getting yourself protected against yellow fever before you go is imperative, an expert says. What is yellow fever? According to Dr. Jill Weatherhead, an assistant professor of tropical medicine and infectious diseases at Baylor College of Medicine in Houston, it’s a viral illness endemic to… read on > read on >
-300x200.jpg)
-300x169.jpg)
